Steven Shallcross

Steven A. Shallcross is CEO, CFO, Treasurer, and Director at Theriva Biologics, Inc. since 2015.
Former roles include Independent Non-Executive Director at Elys BMG Group, Inc. from 2019 to 2024; Independent Director at Twin Vee PowerCats Co. from 2021 to 2022; CFO, Secretary, Treasurer, and Executive VP at Nuo Therapeutics, Inc. from 2013 to 2015; Chief Financial Officer, Treasurer, and Senior VP at Vanda Pharmaceuticals, Inc. from 2005 to 2009; Chief Financial Officer and Executive Vice President at Innocoll Holdings, Inc. and Innocoll AG from 2009 to 2011; Chief Financial Officer at Senseonics, Inc. from 2011 to 2012; Chief Financial Officer, Treasurer, and Executive VP at GPM Empire from 2012 to 2013; Chief Financial Officer and Vice President-Finance at Bering Truck Corp.
from 1997 to 2001; Vice President-Operations at Precision Scientific, Inc. from 1993 to 1997; Chief Financial Officer, Treasurer, and Senior VP at Middlebrook Pharmaceuticals, Inc. from 2001 to 2005; Independent Director at Forza X1, Inc.; Director at Financial Executives International; and Chief Financial Officer at Innocoll, Inc. Education includes an undergraduate degree from the University of Illinois in 1983 and an MBA from The University of Chicago Booth School of Business in 1994.